These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19245384)

  • 1. Feasibility of completing an accelerated vaccine series for homeless adults.
    Nyamathi AM; Sinha K; Saab S; Marfisee M; Greengold B; Leake B; Tyler D
    J Viral Hepat; 2009 Sep; 16(9):666-73. PubMed ID: 19245384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a nurse-managed program on hepatitis A and B vaccine completion among homeless adults.
    Nyamathi A; Liu Y; Marfisee M; Shoptaw S; Gregerson P; Saab S; Leake B; Tyler D; Gelberg L
    Nurs Res; 2009; 58(1):13-22. PubMed ID: 19092551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of behavioral interventions to improve vaccination compliance in homeless adults.
    Greengold B; Nyamathi A; Kominski G; Wiley D; Lewis MA; Hodge F; Singer M; Spiegel B
    Vaccine; 2009 Jan; 27(5):718-25. PubMed ID: 19041351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis A/B vaccine completion among homeless adults with history of incarceration.
    Nyamathi AM; Marlow E; Branson C; Marfisee M; Nandy K
    J Forensic Nurs; 2012 Mar; 8(1):13-22. PubMed ID: 22372394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nursing case management, peer coaching, and hepatitis a and B vaccine completion among homeless men recently released on parole: randomized clinical trial.
    Nyamathi A; Salem BE; Zhang S; Farabee D; Hall B; Khalilifard F; Leake B
    Nurs Res; 2015; 64(3):177-89. PubMed ID: 25932697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Completion and subject loss within an intensive hepatitis vaccination intervention among homeless adults: the role of risk factors, demographics, and psychosocial variables.
    Stein JA; Nyamathi AM
    Health Psychol; 2010 May; 29(3):317-23. PubMed ID: 20496986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twinrix vaccination schedules among injecting drug users.
    Brim N; Zaller N; Taylor LE; Feller E
    Expert Opin Biol Ther; 2007 Mar; 7(3):379-89. PubMed ID: 17309329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination against hepatitis A and B in persons subject to homelessness in inner Sydney: vaccine acceptance, completion rates and immunogenicity.
    Poulos RG; Ferson MJ; Orr KJ; McCarthy MA; Botham SJ; Stern JM; Lucey A
    Aust N Z J Public Health; 2010 Apr; 34(2):130-5. PubMed ID: 23331355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults.
    Tsai IJ; Chang MH; Chen HL; Ni YH; Lee PI; Chiu TY; Safary A
    Vaccine; 2000 Oct; 19(4-5):437-41. PubMed ID: 11027806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
    Kurugöl Z; Mutlubaş F; Ozacar T
    Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule.
    Keystone JS; Hershey JH
    Int J Infect Dis; 2008 Jan; 12(1):3-11. PubMed ID: 17643334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a hepatitis A/B vaccination program using an accelerated schedule among high-risk inmates, Los Angeles County Jail, 2007-2010.
    Costumbrado J; Stirland A; Cox G; El-Amin AN; Miranda A; Carter A; Malek M
    Vaccine; 2012 Nov; 30(48):6878-82. PubMed ID: 22989688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule.
    Gilca V; Sauvageau C; Boulianne N; De Serres G; Couillard M; Krajden M; Ouakki M; Murphy D; Trevisan A; Dionne M
    Hum Vaccin Immunother; 2014; 10(8):2438-45. PubMed ID: 25424952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to hepatitis A and hepatitis B multi-dose vaccination schedules among adults in the United Kingdom: a retrospective cohort study.
    Johnson KD; Lu X; Zhang D
    BMC Public Health; 2019 Apr; 19(1):404. PubMed ID: 30987613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges with hepatitis B vaccination of high risk adults - A pilot program.
    Bridges CB; Watson TL; Nelson NP; Chavez-Torres M; Fineis P; Ntiri-Reid B; Wake E; Leahy JM; Kurian AK; Hall MAK; Kennedy ED
    Vaccine; 2019 Aug; 37(35):5111-5120. PubMed ID: 31303523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the Extended Health Control Belief Model to Predict Hepatitis A and B Vaccinations.
    Reynolds GL; Nguyen HH; Singh-Carlson S; Fisher DG; Odell A; Xandre P
    Public Health Nurs; 2016 Sep; 33(5):430-9. PubMed ID: 26918304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
    Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis vaccination adherence and completion rates and factors associated with low compliance: A claims-based analysis of U.S. adults.
    LaMori J; Feng X; Pericone CD; Mesa-Frias M; Sogbetun O; Kulczycki A
    PLoS One; 2022; 17(2):e0264062. PubMed ID: 35176102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine induced Hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease.
    Shapiro AJ; Esther CR; Leigh MW; Dellon EP
    Vaccine; 2013 Jan; 31(6):906-11. PubMed ID: 23261047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.